Insulet
PODD
#1092
Rank
HK$133.55 B
Marketcap
HK$1,902
Share price
-1.49%
Change (1 day)
38.49%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - P/B ratio

P/B ratio as of March 2025 : 14.2

According to Insulet's latest financial reports the company has a price-to-book ratio of 8.66083.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Insulet - P/B ratio (from 2007 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-3116.6-19.56%
2023-12-3120.7-51.82%
2022-12-3142.930.1%
2021-12-3133.018.14%
2020-12-3127.9-80.25%
2019-12-31141538.77%
2018-12-3122.1-12.61%
2017-12-3125.3-26.08%
2016-12-3134.3-45.82%
2015-12-3163.2104.45%
2014-12-3130.989.33%
2013-12-3116.3-29.67%
2012-12-3123.2115.35%
2011-12-3110.81.43%
2010-12-3110.64.26%
2009-12-3110.244.87%
2008-12-317.047.95%
2007-12-316.52
2006-12-31N/A
2005-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
1.75-87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
4.59-67.61%๐Ÿ‡บ๐Ÿ‡ธ USA
12.7-10.25%๐Ÿ‡บ๐Ÿ‡ธ USA
5.49-61.26%๐Ÿ‡บ๐Ÿ‡ธ USA
4.70-66.84%๐Ÿ‡บ๐Ÿ‡ธ USA
2.43-82.86%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
50.5 255.76%๐Ÿ‡บ๐Ÿ‡ธ USA